Transparency Requirements. 41.1 The parties acknowledge that, except for any information which is exempt from disclosure in accordance with the provisions of the FOIA, the content of this Contract is not Confidential Information. The CUSTOMER shall be responsible for determining in its absolute discretion whether any of the content of the Contract is exempt from disclosure in accordance with the provisions of the FOIA. Notwithstanding any other term of this Contract, the CONTRACTOR hereby gives his consent for the CUSTOMER to publish the Contract in its entirety, (but with any information which is exempt from disclosure in accordance with the provisions of the FOIA redacted) including from time to time agreed changes to the Contract, to the general public.
Transparency Requirements. 1. Contractor shall facilitate access to and correction of any factually inaccurate student PII in response to a request from a local education provider or from LCS.
Transparency Requirements i. The MCOP must include a term in all FDR agreements that requires the FDR to grant ODM access to documents and other records ODM deems relevant to evaluate the FDR's performance thereunder.
Transparency Requirements. The parties acknowledge that, except for any information which is exempt from disclosure in accordance with the provisions of the FOIA, the content of this Contract is not Confidential Information. The CUSTOMER shall be responsible for determining in its absolute discretion whether any of the content of the Contract is exempt from disclosure in accordance with the provisions of the FOIA. Notwithstanding any other term of this Contract, the CONTRACTOR hereby gives his consent for the CUSTOMER to publish the Contract in its entirety, (but with any information which is exempt from disclosure in accordance with the provisions of the FOIA redacted) including from time to time agreed changes to the Contract, to the general public. The CUSTOMER may consult with the CONTRACTOR to inform its decision regarding any redactions but the CUSTOMER shall have the final decision in its absolute discretion. The CONTRACTOR shall assist and cooperate with the CUSTOMER to enable the CUSTOMER to publish this Contract. For and on behalf of the CUSTOMER NHS Blood and Transplant For and on behalf of the CONTRACTOR Phoenix Software Ltd Authorised signatory: Name: Authorised signatory: Name: Xxxx Xxxxxx Title: Title: NHS External Account Manager Date: Date: 21st March 2013 ANNEX A TO THE CONTRACT ClauseS ALTERNATIVE CLAUSES AND ADDITIONAL CLAUSES
Transparency Requirements. (a) The Borrower (the “Designated Reporting Entity”) hereby agrees to make available, in accordance with the provisions of this Agreement, to the Agent, the Collateral Agent, each EU/UK Institutional Investor Lender, any requesting EU/UK Institutional Investor Potential Lender and any requesting Competent Authority (together, the “Relevant Recipients”):
Transparency Requirements. WCER shall provide transparency to parents, school districts and the public about its collection and use of PII for ACCESS for XXXx test administrations by posting the following information in plain English on its public website:
Transparency Requirements. (a) In relation to the reporting obligations under the Transparency Requirements, pursuant to Article 7(2) of the Securitisation Regulations, the Company and the Originator hereby designate the Company as the designated entity required to fulfil the reporting obligations of Article 7(1) of the Securitisation Regulations, and the Company accepts such designation and agrees to take all necessary steps required to fulfil the Transparency Requirements.
Transparency Requirements. (a) The Borrower (the “Designated Reporting Entity”) hereby agrees to be designated, pursuant to Article 7(2) of the EU Securitisation Regulation, as the designated entity required to fulfil the Transparency Requirements, and agrees to make available to the Affected Lenders, the Administrative Agent, any potential investor herein (as determined by the Collateral Manager) and the competent authorities (as determined under the EU Securitisation Regulation) (together, the “Relevant Recipients”) the duly completed reports provided in Annex 4 and Annex 12 of the European Securities and Markets Authority reporting templates for Article 7 of the EU Securtisation Regulation (in effect on the Closing Date unless otherwise expressly agreed upon in writing by the Borrower and the Affected Lenders the “Transparency Requirements”) no later than one month after the applicable Quarterly Payment Date (each such date, the “Reporting Deadline”). The Transparency Reports will not include any information which the Collateral Manager, in its sole discretion, believes is subject to any legal or contractual obligation of confidentiality or restricting the processing of personal data. For the purposes of the Transparency Requirements, the first reporting date for the Transparency Reports (as defined below) will be no later than the Quarterly Payment Date occurring in October 2023.
Transparency Requirements. 8.1. Xxxxxx will facilitate access to and correction of any inaccurate Covered Information in response to a request from Customer.
Transparency Requirements. SANOFI is committed to transparency in its interactions with healthcare professionals and health care organizations/institutions consistent with applicable laws in countries in which SANOFI has Affiliates. Information relating to payments or other transfers of value to U.S. "covered recipients" under or related to this Agreement will be collected and reported as required under U.S. federal and state laws and regulations, including the "sunshine" regulations set forth in 42 CFR Parts 402 and 403, which require that certain payments, and other transfers of value, whether direct or indirect (through a third party), be collected and reported to the U.S. government for subsequent public reporting. To the extent that the services provided as part of this Agreement are "Research" as defined in the federal regulations to include "a systematic investigation designed to develop or contribute to generalizable knowledge relating broadly to public health, including behavioral and social-sciences research", which encompasses both basic and applied research, (42 CFR § 403.902), and which is subject to a written agreement, a research protocol or both, will be reported consistent with the special rules for research payments. (42 CFR §403.904(f)). To the extent that any payments or transfers of value fall outside the "Research" as defined in the federal regulations, they will be reported as required consistent with applicable federal regulations. All state reporting will be consistent with state requirements Representation Regarding Transfers of Value to Physicians or Teaching Hospitals for U.S. "Sunshine" Reporting Purposes: COMPANY represents that no portion of any payment made under this Agreement is or will be passed on to: • any physician (Medical Doctor (MD), Doctor of Osteopathic Medicine (DO), MD or DO Fellow, Dentist, Dental surgeon, Podiatrist, Optometrist, or Chiropractor), licensed in the U.S. ("Physician"). Salary paid to a Physician shall not be considered to include amounts passed on under this Agreement if the amount of the salary is determined without consideration of the amounts paid under this Agreement and COMPANY has not used and will not use any portion of payments made under this Agreement in determining the amount of non-salary compensation to any Physician; or • any U.S. Teaching Hospital
